Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| R1 RCM Inc. | 20 | 0 | 1 | 0 | 11,10 € | 17,41 € | 56,84 % |
| Kala Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | 5,50 € | 19,50 € | 254,52 % |
| MacroGenics Inc. | 13 | 0 | 1 | 0 | 4,17 € | 12,42 € | 197,81 % |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | 19,10 € | - | - |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | 74,02 € | 80,00 € | 8,08 % |
| Lemaitre Vascular Inc | 2 | 0 | 0 | 0 | 72,00 € | 73,50 € | 2,08 % |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | 46,80 € | 50,00 € | 6,84 % |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | 68,84 € | 100,00 € | 45,26 % |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | 1,85 € | 6,45 € | 248,04 % |
| Syros Pharmaceuticals Inc. | 6 | 1 | 0 | 0 | 5,60 € | 13,60 € | 142,81 % |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | 23,40 € | 24,97 € | 6,72 % |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | 40,00 € | 46,08 € | 15,21 % |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | 39,23 € | 70,00 € | 78,46 % |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | 22,40 € | 45,21 € | 101,83 % |
| Immunogen Inc. | 4 | 0 | 0 | 0 | 28,97 € | - | - |
| Anika Therapeutics | 5 | 0 | 0 | 0 | 24,00 € | 28,29 € | 17,88 % |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | 5,76 € | 11,05 € | 91,79 % |
| Cerus Corp. | 4 | 0 | 0 | 0 | 1,71 € | 3,26 € | 90,65 % |
| Healthstream Inc. | 4 | 0 | 0 | 0 | 25,60 € | 29,29 € | 14,43 % |
| Dynavax Technologies Corp | 2 | 0 | 0 | 0 | 11,18 € | 26,95 € | 141,16 % |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 0 | 0 | 1,70 € | 5,34 € | 213,33 % |
| Innoviva Inc. | 3 | 0 | 0 | 0 | 14,70 € | 30,00 € | 104,08 % |
| Brainstorm Cell | 1 | 0 | 0 | 0 | 0,42 € | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | 5,85 € | - | - |
| Cytosorbents Corp. | 4 | 0 | 0 | 0 | 0,81 € | 3,74 € | 359,41 % |